AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7585287 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (11% of total energy from protein for group MH, 17% for group FH, 10% for group NL)
Number of subjects: 21
Study 7585287 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet
Number of subjects: 21
Study 2246576 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin systemically
Number of subjects: 25
Study 2246576 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin locally (ointment)
Number of subjects: 25
Study 6446852 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Treatment Group (Acupuncture)
Number of subjects: 0
Study 6446852 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed Treatment Group (Acupuncture after initial control)
Number of subjects: 0
Study 6446852 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (Immediate and Delayed Treatment)
Number of subjects: 0
Study 6446852 — intervention group
Group type: COMPARATOR
Intervention: Inadequate Treatment Group (Control)
Number of subjects: 0
Study 6403280 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2-rebreathing method
Number of subjects: 50
Study 30124729 — intervention group
Group type: EXPERIMENTAL
Intervention: SB208 4%
Number of subjects: 0
Study 30124729 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled SB208-treated groups
Number of subjects: 0
Study 30124729 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study 26115978 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus cisplatin (NACT group)
Number of subjects: 219
Study 26115978 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus cisplatin (TP group)
Number of subjects: 219
Study 26115978 — intervention group
Group type: COMPARATOR
Intervention: Control group (direct surgery, DS group)
Number of subjects: 219
Study 26115978 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus cisplatin (IP group)
Number of subjects: 219
Study 26115978 — intervention group
Group type: EXPERIMENTAL
Intervention: NACT (irinotecan plus cisplatin or paclitaxel plus cisplatin)
Number of subjects: 219
Study 24933106 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 51
Study 24933106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 22684355 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 mcg twice daily
Number of subjects: 77
Study 22684355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 20332245 — intervention group
Group type: EXPERIMENTAL
Intervention: GH therapy for 4 months (36 microg/kg x d)
Number of subjects: 35
Study 20332245 — intervention group
Group type: COMPARATOR
Intervention: Delayed start of GH therapy (untreated for 4 months, then GH for 4 months)
Number of subjects: 35
Study 18564796 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine (initial dose 50 mg infused over 30 minutes, dose intervals of 5 mg)
Number of subjects: 0
Study 18564796 — intervention group
Group type: EXPERIMENTAL
Intervention: Mephentermine (initial dose 50 mg infused over 30 minutes, dose intervals of 5 mg)
Number of subjects: 0
Study 15373702 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication (treated with omeprazole and antibiotics)
Number of subjects: 1108
Study 15373702 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 1108
Study 15373702 — intervention group
Group type: COMPARATOR
Intervention: No treatment (untreated group)
Number of subjects: 1108
Study 15373702 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants without gastric atrophy, intestinal metaplasia, and dysplasia
Number of subjects: 1108
Study 11197291 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrogastrography (EGG)
Number of subjects: 22
Study 11197291 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric emptying of radiopaque pellets
Number of subjects: 22
Study 11197291 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroscopy
Number of subjects: 22
Study 9136213 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple objective tests for hand-arm vibration syndrome
Number of subjects: 0
Study 9136213 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold provocation testing
Number of subjects: 0
Study 8195678 — intervention group
Group type: EXPERIMENTAL
Intervention: Prinomide (1500 mg/day)
Number of subjects: 267
Study 8195678 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (1500 mg/day)
Number of subjects: 267
Study 8195678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 2977043 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dose of 3 X 100 mg MPA
Number of subjects: 40
Study 2977043 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly changing scheme with 2 X 10 mg Tamoxifen and 3 X 100 mg MPA
Number of subjects: 40
Study 2977043 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dose of 1000 mg MPA daily (in 4 patients with ovarian carcinoma)
Number of subjects: 40
Study 2977043 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol concentration measured at the same time
Number of subjects: 40
Study 28986606 — intervention group
Group type: EXPERIMENTAL
Intervention: Breviscapine (120 mg daily, 40 mg three times a day for 14 days)
Number of subjects: 17
Study 28986606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 25344059 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating and Exercise Lifestyle Program
Number of subjects: 134
Study 25344059 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 134
Study 25241373 — intervention group
Group type: EXPERIMENTAL
Intervention: Question wording asking if pregnancies were planned or wanted
Number of subjects: 8575
Study 25241373 — intervention group
Group type: EXPERIMENTAL
Intervention: Question wording with additional information on reasons for not using contraception
Number of subjects: 8575
Study 25241373 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analysis comparing unplanned vs unwanted pregnancies
Number of subjects: 8575
Study 22713347 — intervention group
Group type: EXPERIMENTAL
Intervention: Community member providing As education and WAs testing
Number of subjects: 100
Study 22713347 — intervention group
Group type: COMPARATOR
Intervention: Outside representative performing As education and WAs testing
Number of subjects: 100
Study 20559656 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (RV5)
Number of subjects: 23000
Study 17010994 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine treatment (10-20mg/day)
Number of subjects: 271
Study 16234007 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg twice daily with placebo
Number of subjects: 74
Study 16234007 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg twice daily with codeine 30 mg 4 times/day
Number of subjects: 74
Study 16234007 — intervention group
Group type: COMPARATOR
Intervention: Placebo with codeine 30 mg 4 times/day
Number of subjects: 74
Study 16234007 — intervention group
Group type: COMPARATOR
Intervention: Placebo with placebo
Number of subjects: 74
Study 12483729 — intervention group
Group type: EXPERIMENTAL
Intervention: IDEC‐131 (2.5 mg/kg to 10.0 mg/kg)
Number of subjects: 85
Study 12483729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 9690596 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (2 mL 0.5% dibucaine)
Number of subjects: 30
Study 9690596 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia (20 mL 2% mepivacaine)
Number of subjects: 30
Study 8279421 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day diet record (FDDR)
Number of subjects: 0
Study 8279421 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-related diet-habits questionnaire
Number of subjects: 0
Study 8279421 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-frequency questionnaire (FFQ)
Number of subjects: 0
Study 2686547 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin (400 mg three times a day)
Number of subjects: 10
Study 2686547 — intervention group
Group type: EXPERIMENTAL
Intervention: pefloxacin (400 mg three times a day)
Number of subjects: 10
Study 2686547 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin and pefloxacin
Number of subjects: 10
Study 4425916 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 20
Study 31999316 — intervention group
Group type: COMPARATOR
Intervention: text-only visualization
Number of subjects: 40
Study 31999316 — intervention group
Group type: COMPARATOR
Intervention: line graph visualization
Number of subjects: 40
Study 31999316 — intervention group
Group type: EXPERIMENTAL
Intervention: visual analogy visualization
Number of subjects: 40
Study 31999316 — intervention group
Group type: EXPERIMENTAL
Intervention: number line visualization
Number of subjects: 40
Study 30480860 — intervention group
Group type: EXPERIMENTAL
Intervention: Active sTMS
Number of subjects: 120
Study 30480860 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 120
Study 30480860 — intervention group
Group type: EXPERIMENTAL
Intervention: Active sTMS (10 weeks)
Number of subjects: 120
Study 30480860 — intervention group
Group type: EXPERIMENTAL
Intervention: Open/active phase sTMS
Number of subjects: 120
Study 27564925 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy (λ of 640 nm and SAEF of 1.06 J/cm2)
Number of subjects: 120
Study 27564925 — intervention group
Group type: EXPERIMENTAL
Intervention: LED therapy (λ of 660 ± 20 nm and SAEF of 0.24 J/cm2)
Number of subjects: 120
Study 27564925 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 27564925 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 120
Study 27383132 — intervention group
Group type: EXPERIMENTAL
Intervention: RombergLab software using a low cost force platform
Number of subjects: 20
Study 27383132 — intervention group
Group type: COMPARATOR
Intervention: Clinical approved software and force platform
Number of subjects: 20
Study 25187339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist Group (PG)
Number of subjects: 201
Study 25187339 — intervention group
Group type: COMPARATOR
Intervention: Nurse Group (NG)
Number of subjects: 201
Study 22033367 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warm-up (10 minutes of stationary cycling at 70% of predicted maximum heart rate)
Number of subjects: 21
Study 22033367 — intervention group
Group type: COMPARATOR
Intervention: No warm-up (sat quietly)
Number of subjects: 21
Study 18842959 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group with personally relevant statement
Number of subjects: 173
Study 18842959 — intervention group
Group type: COMPARATOR
Intervention: Control group without personally relevant statement
Number of subjects: 173
Study 17257479 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral linezolid during hospitalization and after discharge
Number of subjects: 3
Study 17257479 — intervention group
Group type: COMPARATOR
Intervention: IV vancomycin/oral linezolid switch
Number of subjects: 3
Study 17257479 — intervention group
Group type: COMPARATOR
Intervention: IV vancomycin
Number of subjects: 3
Study 15165660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailing FOBT cards and reminders 2 weeks prior to a scheduled appointment
Number of subjects: 119
Study 15165660 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 119
Study 11586040 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD not removed, treated with trimethoprim and sulfamethoxazole
Number of subjects: 43
Study 11586040 — intervention group
Group type: COMPARATOR
Intervention: IUD removed, treated with trimethoprim and sulfamethoxazole
Number of subjects: 43
Study 10442373 — intervention group
Group type: EXPERIMENTAL
Intervention: Uracil/tegafur (UFT) 250 mg/m2/day plus oral calcium folinate 45 mg/day
Number of subjects: 0
Study 7599544 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil with bupivacaine
Number of subjects: 54
Study 7599544 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl with bupivacaine
Number of subjects: 54
Study 2213107 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg/d)
Number of subjects: 24
Study 2213107 — intervention group
Group type: COMPARATOR
Intervention: 13-cis retinoic acid (1 mg/kg/d)
Number of subjects: 24
Study 859784 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran-70
Number of subjects: 100
Study 859784 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 100
Study 859784 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 100
Study 30981653 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-deployment training for Hajj duties
Number of subjects: 1216
Study 30981653 — intervention group
Group type: COMPARATOR
Intervention: Non Hajj HCWs (no pre-deployment training)
Number of subjects: 1216
Study 28625246 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow hemodialysis (HFHD)
Number of subjects: 60
Study 28625246 — intervention group
Group type: COMPARATOR
Intervention: Routine hemodialysis (HD)
Number of subjects: 60
Study 25884819 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored implementation programme
Number of subjects: 444
Study 25884819 — intervention group
Group type: COMPARATOR
Intervention: Standardised training and feedback
Number of subjects: 444
Study 24270457 — intervention group
Group type: EXPERIMENTAL
Intervention: ATM Tabata interval-training program (sprinting on an ATM at 7.5 miles⋅h with front jets turned on at 80, 85, 90, and 95% progressively increasing throughout the 8 weeks)
Number of subjects: 25
Study 24270457 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) which only completed Pre‐ and Posttesting
Number of subjects: 25
Study 21350025 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human IL-6 (rhIL-6) infusion into the peritendinous tissue of the Achilles tendon
Number of subjects: 14
Study 21350025 — intervention group
Group type: COMPARATOR
Intervention: exercise group performing a 1-h treadmill run (12 km/h, 2% uphill)
Number of subjects: 14
Study 19106357 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (MTX) injected intravascularly at 100 mg/m² plus 200 mg/m² in 500 mL of normal saline solution with folinic acid rescue
Number of subjects: 50
Study 19106357 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 50
Study 17179377 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (n = 13)
Number of subjects: 35
Study 17179377 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (n = 22)
Number of subjects: 35
Study 17179377 — intervention group
Group type: EXPERIMENTAL
Intervention: Intussusception length > 3.5 cm
Number of subjects: 35
Study 15250831 — intervention group
Group type: EXPERIMENTAL
Intervention: Exfoliative cytology (EC) combined with DNA-image cytometry
Number of subjects: 98
Study 15250831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytology yielding tumor cell-positive, suspicious, or doubtful results
Number of subjects: 98
Study 15250831 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-cytometry
Number of subjects: 98
Study 15250831 — intervention group
Group type: COMPARATOR
Intervention: Histology
Number of subjects: 98
Study 11230464 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cycles of 4'-epidoxorubicin 60 mg/m² days 1 and 2 and ifosfamide 1.8 g/m² days 1 through 5, with hydration, mesna, and granulocyte colony-stimulating factor
Number of subjects: 104
Study 11230464 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 104
Study 11230464 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cycles of 4'-epidoxorubicin and ifosfamide
Number of subjects: 104
Study 9922777 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil-mitomycin C regimen with radiotherapy
Number of subjects: 2
Study 9922777 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C
Number of subjects: 2
Study 9922777 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil-cisplatin regimen
Number of subjects: 2
Study 1291521 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% citric acid treatment to remove smear layer with Tubliseal
Number of subjects: 60
Study 1291521 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% citric acid treatment to remove smear layer with Vitrebond
Number of subjects: 60
Study 1291521 — intervention group
Group type: COMPARATOR
Intervention: Smear layer intact with Tubliseal
Number of subjects: 60
Study 1291521 — intervention group
Group type: COMPARATOR
Intervention: Smear layer intact with Vitrebond
Number of subjects: 60
Study 6512869 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational Emotive Therapy (RET)
Number of subjects: 16
Study 6512869 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 16
Study 30796868 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomechanical correction, DN, TrPs-pressure release
Number of subjects: 87
Study 30796868 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic exercises, DN, TrPs-pressure release
Number of subjects: 87
Study 30099354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2)
Number of subjects: 71
Study 30099354 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 71
Study 26834052 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored face-to-face counseling session, audio quit materials, printed quit materials, Quitline contact details
Number of subjects: 55
Study 26834052 — intervention group
Group type: COMPARATOR
Intervention: Printed quit materials, Quitline contact details
Number of subjects: 55
Study 26834052 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined annual point prevalence quit rate
Number of subjects: 55
Study 24934783 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based lifestyle intervention (LI) including diet (500 to 1,000 kcal per day deficit) and physical activity (150 to 200 minutes of moderate-intensity physical activity per week) for 24 months
Number of subjects: 338
Study 24934783 — intervention group
Group type: COMPARATOR
Intervention: Mail-based delivery of general health information alone
Number of subjects: 338
Study 24934783 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based lifestyle intervention (LI)
Number of subjects: 338
Study 22710783 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic-guided distal locking procedures
Number of subjects: 100
Study 22710783 — intervention group
Group type: COMPARATOR
Intervention: Free-hand fluoroscopic-guided distal locking procedures
Number of subjects: 100
Study 19172250 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic drink
Number of subjects: 96
Study 19172250 — intervention group
Group type: COMPARATOR
Intervention: Non-alcoholic drink (placebo)
Number of subjects: 96
Study 17429726 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pantoprazole (80 mg BID for 3 days)
Number of subjects: 25
Study 17429726 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pantoprazole (80 mg IV bolus and 8 mg/hr infusion for 3 days)
Number of subjects: 25
Study 14767029 — intervention group
Group type: EXPERIMENTAL
Intervention: FTY (0.25-3.5 mg)
Number of subjects: 16
Study 14767029 — intervention group
Group type: EXPERIMENTAL
Intervention: FTY (0.25-2 mg)
Number of subjects: 16
Study 14767029 — intervention group
Group type: EXPERIMENTAL
Intervention: FTY (3.5 mg)
Number of subjects: 16
Study 14767029 — intervention group
Group type: EXPERIMENTAL
Intervention: FTY (0.25-2 mg) or (3.5 mg)
Number of subjects: 16
Study 14767029 — intervention group
Group type: EXPERIMENTAL
Intervention: FTY
Number of subjects: 16
Study 14767029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 14767029 — intervention group
Group type: EXPERIMENTAL
Intervention: FTY (high-dose)
Number of subjects: 16
Study 11436678 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide 5-mononitrate (Mononit) 10 or 20 mg twice a day
Number of subjects: 13
Study 9602958 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 60
Study 9602958 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (Control)
Number of subjects: 60
Study 7625339 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF)
Number of subjects: 7
Study 7625339 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-fat diet (MF)
Number of subjects: 7
Study 7625339 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (HF)
Number of subjects: 7
Study 2575572 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin administration for two days
Number of subjects: 54
Study 2575572 — intervention group
Group type: COMPARATOR
Intervention: No somatostatin administration (Control)
Number of subjects: 54
Study 2575572 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin administration
Number of subjects: 54
Study 31123 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminar air flow group
Number of subjects: 90
Study 31123 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 31123 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminar air flow group (Aplastic anemia)
Number of subjects: 90
Study 31123 — intervention group
Group type: COMPARATOR
Intervention: Control group (Aplastic anemia)
Number of subjects: 90
Study 31123 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminar air flow group (Acute leukemia)
Number of subjects: 90
Study 31123 — intervention group
Group type: COMPARATOR
Intervention: Control group (Acute leukemia)
Number of subjects: 90
Study 31238784 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat group intervention (70 patients with pre-hospital electrocardiography transmission via WeChat)
Number of subjects: 140
Study 31238784 — intervention group
Group type: COMPARATOR
Intervention: Control group (70 patients without pre-hospital electrocardiography transmission)
Number of subjects: 140
Study 31238784 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat group intervention
Number of subjects: 140
Study 31238784 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study 31237571 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-tip pressure measurement
Number of subjects: 400
Study 31237571 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy (FC)
Number of subjects: 400